Izraēla - angļu - Ministry of Health

eliezer linevitz ltd. - mabofloxacine - tablets - mabofloxacine 80 mg - treatment of skin and soft tissue infections in dogs caused by susceptible strains of microorganisms. treatment of urinary tract infections in dogs caused by susceptible strains of microorganisms. respiratory tract infections caused by sisceptible strains of microorganisms.

Izraēla - angļu - Ministry of Health

linevitz eliezer - mabofloxacine 80 mg - tablets - treatment of skin and soft tissue infections in dogs caused by susceptible strains of microorganisms. treatment of urinary tract infections in dogs caused by susceptible strains of microorganisms. respiratory tract infections caused by sisceptible strains of microorganisms.

Izraēla - angļu - Ministry of Health

eliezer linevitz ltd. - mabofloxacine - tablets - mabofloxacine 20 mg - treatment of skin and soft tissue infections in dogs caused by susceptible strains of microorganisms. treatment of urinary tract infections in dogs caused by susceptible strains of microorganisms. respiratory tract infections caused by sisceptible strains of microorganisms.

Izraēla - angļu - Ministry of Health

linevitz eliezer - mabofloxacine 20 mg - tablets - treatment of skin and soft tissue infections in dogs caused by susceptible strains of microorganisms. treatment of urinary tract infections in dogs caused by susceptible strains of microorganisms. respiratory tract infections caused by sisceptible strains of microorganisms.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

zyvet animal health inc - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

felix pharmaceuticals private limited - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - marbofloxacin - unknown - marbofloxacin antibiotic active 0.0 - active constituent

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - marbofloxacin; clotrimazole; dexamethasone acetate - misc. aural, ophthalmic, oro/naso pharyngeal - marbofloxacin antibiotic active 3.0 mg/ml; clotrimazole imidazole active 10.0 mg/ml; dexamethasone acetate steroid-glucocorticoid active 1.0 mg/ml - ear,nose,throat preps. - dog | bitch | castrate | puppy - otitis externa | acute canine otitis | associated with yeast &/or bac | chronic canine otitis | malassezia pachydermatis | otitis (canine)

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

zoetis inc. - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin 25 mg - zeniquin (marbofloxacin) tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.